New perspectives on osteogenesis imperfecta
- PMID: 21670757
- PMCID: PMC3443407
- DOI: 10.1038/nrendo.2011.81
New perspectives on osteogenesis imperfecta
Abstract
A new paradigm has emerged for osteogenesis imperfecta as a collagen-related disorder. The more prevalent autosomal dominant forms of osteogenesis imperfecta are caused by primary defects in type I collagen, whereas autosomal recessive forms are caused by deficiency of proteins which interact with type I procollagen for post-translational modification and/or folding. Factors that contribute to the mechanism of dominant osteogenesis imperfecta include intracellular stress, disruption of interactions between collagen and noncollagenous proteins, compromised matrix structure, abnormal cell-cell and cell-matrix interactions and tissue mineralization. Recessive osteogenesis imperfecta is caused by deficiency of any of the three components of the collagen prolyl 3-hydroxylation complex. Absence of 3-hydroxylation is associated with increased modification of the collagen helix, consistent with delayed collagen folding. Other causes of recessive osteogenesis imperfecta include deficiency of the collagen chaperones FKBP10 or Serpin H1. Murine models are crucial to uncovering the common pathways in dominant and recessive osteogenesis imperfecta bone dysplasia. Clinical management of osteogenesis imperfecta is multidisciplinary, encompassing substantial progress in physical rehabilitation and surgical procedures, management of hearing, dental and pulmonary abnormalities, as well as drugs, such as bisphosphonates and recombinant human growth hormone. Novel treatments using cell therapy or new drug regimens hold promise for the future.
Figures
Similar articles
-
Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta.Cell Tissue Res. 2010 Jan;339(1):59-70. doi: 10.1007/s00441-009-0872-0. Epub 2009 Oct 28. Cell Tissue Res. 2010. PMID: 19862557 Free PMC article. Review.
-
Abnormal type I collagen post-translational modification and crosslinking in a cyclophilin B KO mouse model of recessive osteogenesis imperfecta.PLoS Genet. 2014 Jun 26;10(6):e1004465. doi: 10.1371/journal.pgen.1004465. eCollection 2014 Jun. PLoS Genet. 2014. PMID: 24968150 Free PMC article.
-
Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation.Curr Opin Pediatr. 2014 Aug;26(4):500-7. doi: 10.1097/MOP.0000000000000117. Curr Opin Pediatr. 2014. PMID: 25007323 Free PMC article. Review.
-
Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta.N Engl J Med. 2006 Dec 28;355(26):2757-64. doi: 10.1056/NEJMoa063804. N Engl J Med. 2006. PMID: 17192541 Free PMC article.
-
New genes in bone development: what's new in osteogenesis imperfecta.J Clin Endocrinol Metab. 2013 Aug;98(8):3095-103. doi: 10.1210/jc.2013-1505. Epub 2013 Jun 14. J Clin Endocrinol Metab. 2013. PMID: 23771926 Free PMC article. Review.
Cited by
-
TMEM38B Gene Mutation Associated With Osteogenesis Imperfecta.Cureus. 2024 Sep 9;16(9):e69021. doi: 10.7759/cureus.69021. eCollection 2024 Sep. Cureus. 2024. PMID: 39385871 Free PMC article.
-
Osteoclast indices in osteogenesis imperfecta: systematic review and meta-analysis.JBMR Plus. 2024 Aug 21;8(11):ziae112. doi: 10.1093/jbmrpl/ziae112. eCollection 2024 Nov. JBMR Plus. 2024. PMID: 39372603 Free PMC article.
-
Multiple dermatofibromas in a patient with Ehlers-Danlos syndrome: a case report.J Med Case Rep. 2024 Aug 31;18(1):417. doi: 10.1186/s13256-024-04628-7. J Med Case Rep. 2024. PMID: 39215353 Free PMC article.
-
Multidisciplinary Management of Pregnancy in Patients With Osteogenesis Imperfecta Type 3.Perm J. 2024 Sep 16;28(3):190-193. doi: 10.7812/TPP/23.168. Epub 2024 Jun 24. Perm J. 2024. PMID: 38980766 Free PMC article. No abstract available.
-
Osteogenesis imperfecta type 10 and the cellular scaffolds underlying common immunological diseases.Genes Immun. 2024 Aug;25(4):265-276. doi: 10.1038/s41435-024-00277-4. Epub 2024 May 29. Genes Immun. 2024. PMID: 38811682 Review.
References
-
- Marini JC. In: Nelson Textbook of Pediatrics. Behrman RE, Kliegman RM, Jensen RM, editors. Philadelphia: Saunders; 2004. pp. 2336–2338.
-
- Morello R, et al. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell. 2006;127:291–304. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
